Advertisement
Advertisement

Contact Person

Dr. Elinor Switzer

Managing Editor

Phone: +49 (0)711 - 2 29 87 63
Fax: +49 (0)711 - 2 29 87 65
send an Email


Archive

Review on the value of graduated elastic compression stockings after deep vein thrombosis

Journal: Thrombosis and Haemostasis
ISSN: 0340-6245
Topic:

COX-2 inhibitors and the thrombotic risk

DOI: http://dx.doi.org/10.1160/TH06-05-0258
Issue: 2006: 96/4 (Oct) pp. 391-543
Pages: 441-445

Review on the value of graduated elastic compression stockings after deep vein thrombosis

Stavros K. Kakkos, Stella S. Daskalopoulou, Marios E. Daskalopoulos, Andrew N. Nicolaides, George Geroulakos
Vascular Unit, Ealing Hospital and Department of Vascular Surgery, Imperial College London, London, UK

Keywords

prevention, venous thromboembolism, Graduated elastic compression stockings, recurrent deep vein thrombosis, post-thrombotic syndrome

Summary

Graduated elastic compression stockings (GECS) are commonly used in the primary prevention of deep vein thrombosis (DVT); however, their role in preventing recurrent DVT and also post-thrombotic syndrome is less well established. The aim of this review was to investigate the effect of GECS after DVT. A literature search was performed by two independent searchers in order to identify randomised controlled trials on the effect of GECS in preventing recurrent DVT and post-thrombotic syndrome. Four randomised trials, including 537 patients, were identified. Two of the studies demonstrated that below-knee GECS significantly reduced post-thrombotic syndrome during follow-up, while a smaller study showed equivocal results. GECS reduced the incidence of post-thrombotic syndrome from 54% to 25.2% [relative risk (RR) 0.47, 95% confidence interval (CI) 0.36–0.61] with the number needed to treat (NNT) being 4 (95% CI 2.7–5.0).The rate of recurrent asymptomatic DVT was also significantly reduced by GECS (RR 0.20, 95% CI 0.06–0.64; NNT 5); the reduction in symptomatic DVT was not significant (RR 0.79, 95% CI 0.50–1.26; NNT 34). In conclusion, there is level Ia evidence to suggest that GECS can significantly reduce the incidence of post-thrombotic syndrome (PTS) after DVT, and therefore these should be routinely prescribed. The evidence for recurrent DVT is less conclusive. Further research is needed towards standardising PTS diagnostic criteria and evaluating more effective preventive measures after DVT.

You may also be interested in...

1.
H. Leon Daneschvar1, Ali Seddighzadeh1, Gregory Piazza2, Samuel Z. Goldhaber1

Thromb Haemost 2008 99 6: 1035-1039

http://dx.doi.org/10.1160/TH08-02-0107

2.
Alexander T. Cohen1, Giancarlo Agnelli2, Frederick A. Anderson3, Juan I. Arcelus4, David Bergqvist5, Josef G. Brecht6, Ian A. Greer7, John A. Heit8, Julia L. Hutchinson9, Ajay K. Kakkar10, Dominique Mottier11, Emmanuel Oger11, Meyer-Michel Samama12, Michael Spannagl13 for the VTE Impact Assessment Group in Europe (VITAE)

Thromb Haemost 2007 98 4: 756-764

http://dx.doi.org/10.1160/TH07-03-0212

3.

P. Girard (1), J. Demaria (2), A. Lillo-Le Louët (3), R. Caliandro (1), J.-L. Le Guillou (4), M. Crespin (5), A. de Sanctis (1), J.-B. Stern (1)

Thromb Haemost 2011 106 6: 1109-1116

http://dx.doi.org/10.1160/TH11-06-0433